Kenya vs Malawi: HIV/AIDS deaths averted by antiretroviral therapy
Kenya
75,293 deaths
in 2024
Malawi
53,389 deaths
in 2024
Kenya rank
8th
Malawi rank
9th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Kenya
- Malawi
How they compare
Kenya currently reports 75,293 deaths against 53,389 deaths in Malawi, a difference of 21,904 deaths.
That makes Kenya's figure about 1.4 times Malawi's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Malawi ahead.
Kenya ranks 8th and Malawi ranks 9th of 157 countries.
Kenya has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Kenya | Malawi | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 18,197 deaths | 9,707 deaths | 8,491 deaths | Kenya |
| 2010s | 71,552 deaths | 46,122 deaths | 25,430 deaths | Kenya |
| 2020s | 75,330 deaths | 53,202 deaths | 22,128 deaths | Kenya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Kenya or Malawi?
- Kenya, at 75,293 deaths against 53,389 deaths in Malawi as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Kenya and Malawi?
- 21,904 deaths, with Kenya ahead.
- How many years of comparable data are there for Kenya and Malawi?
- 35 years are reported by both, from 1990 to 2024.
- How do Kenya and Malawi rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Kenya ranks 8th and Malawi ranks 9th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.